Clinical Trials Directory

Trials / Completed

CompletedNCT02417792

The Association Between Psoriasis and Intestinal Bacterial Population

Status
Completed
Phase
Study type
Observational
Enrollment
46 (actual)
Sponsor
Assuta Hospital Systems · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

At least 20 psoriasis patients will be compared to at least 20 participants without psoriasis Bacterial genomic DNA will be extracted from stool samples of participants. The intestinal bacterial populations will be compared in order to examine whether there are differences between the groups.

Detailed description

Intestinal bacterial population has a significant influence on health and sickness conditions. It affects the development and the function of the immune system (Th2, Th1 or Th17) by bacterial protein expression and by the composition of the bacterial population. Psoriasis is an immune related dermal disease. The trigger for this disease is currently unknown but, it is possible that intestinal bacteria are a factor in its development. Study design: Participants will be divided into 3 groups: * Psoriasis patients treated with topical medications * Psoriasis patients treated with IV or sub-cutaneous medications (e.g biological medications) * Healthy participants (control group) Bacterial genomic DNA will be extracted from stool samples of participants. The intestinal bacterial populations will be compared in order to examine whether there are differences between the groups.

Conditions

Timeline

Start date
2015-05-14
Primary completion
2019-01-06
Completion
2019-02-18
First posted
2015-04-16
Last updated
2019-09-25

Source: ClinicalTrials.gov record NCT02417792. Inclusion in this directory is not an endorsement.

The Association Between Psoriasis and Intestinal Bacterial Population (NCT02417792) · Clinical Trials Directory